Evidence map›Paper›PMID 36721443›Full record

ArticleIranian journal of microbiology2022

Idiopathic methicillin-susceptible

Mohammad Dashtkoohi, Farbod Semnani, Nasser Aghdami, Marjan Sohrabi, Arezoo Salami Khaneshan, Fereshte Ghiasvand, Parnian Adhami Moghadam

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mohammad DashtkoohiStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Farbod SemnaniStudents' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.
Nasser AghdamiDepartment of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Marjan SohrabiDepartment of Infectious Diseases and Tropical Medicines, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Arezoo Salami KhaneshanDepartment of Infectious Diseases and Tropical Medicines, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Fereshte GhiasvandDepartment of Infectious Diseases and Tropical Medicines, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Parnian Adhami MoghadamDepartment of Infectious Diseases and Tropical Medicines, Islamic Azad University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRAcademic Center for Education, Culture and Research · IRIslamic Azad University Medical Branch of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumothorax following right-sided bacterial endocarditis is an infrequent medical complication usually reported in cases with a history of intravenous drug abuse. The following report describes the condition of a girl without congenital heart disease or a history of intravenous drug abuse who developed pneumothorax secondary to endocarditis.

Indexed as

BacteremiaBacterial endocarditisEmpyemaPneumothoraxStaphylococcus aureus

Identifiers

PMID36721443
PMCPMC9867617
OpenAlexW4311729203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.